Market Tracker

09/26 5:16pm ET

Alkermes Plc (NASDAQ:ALKS)

48.58
Delayed Data
As of 3:59pm ET
 -1.00 / -2.02%
Today’s Change
27.14
Today|||52-Week Range
80.71
-38.80%
Year-to-Date

Today’s Trading

Previous close49.58
Today’s open49.50
Day’s range48.34 - 49.67
Volume643,906
Average volume (3 months)879,348
Market cap$7.5B
Dividend yield--
Data as of 3:59pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)-623.81%
Earnings growth (this year)+49.30%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+1.54%
P/E ratioNM
Price/Sales18.85
Price/Book5.69

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-3.40-2.67%
SGENSeattle Genetics Inc-0.12-0.21%
RDYDr.Reddy's Laborator...-0.58-1.21%
MNKMallinckrodt Plc-5.21-6.83%
Data as of 4:02pm ET, 09/26/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$628.3M
Annual profit (last year)-$227.2M
Net profit margin-36.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts